These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22432845)

  • 21. Beclomethasone dipropionate: a second chance for topical steroids as maintenance therapy in ileal Crohn's disease.
    Billioud V; Peyrin-Biroulet L
    Dig Liver Dis; 2011 Jun; 43(6):423-4. PubMed ID: 21530427
    [No Abstract]   [Full Text] [Related]  

  • 22. Reviewing the therapeutic role of budesonide in Crohn's disease.
    López-Sanromán A; Clofent J; Garcia-Planella E; Menchén L; Nos P; Rodríguez-Lago I; Domènech E
    Gastroenterol Hepatol; 2018; 41(7):458-471. PubMed ID: 30007787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.
    Bonovas S; Nikolopoulos GK; Lytras T; Fiorino G; Peyrin-Biroulet L; Danese S
    Br J Clin Pharmacol; 2018 Feb; 84(2):239-251. PubMed ID: 29057539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis.
    Lee YJ; Cheon JH; Kim JH; Yoo S; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
    Yonsei Med J; 2017 Jan; 58(1):144-149. PubMed ID: 27873507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1975; 10(3):166-210. PubMed ID: 172309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?
    Fasci Spurio F; Aratari A; Margagnoni G; Clemente V; Moretti A; Papi C
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):65-71. PubMed ID: 23539393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study.
    Astegiano M; Pagano N; Sapone N; Simondi D; Bertolusso L; Bresso F; Demarchi B; Pellicano R; Bonardi R; Marconi S; Rizzetto M
    Biomed Pharmacother; 2007 Jul; 61(6):370-6. PubMed ID: 17399941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.
    D'Haens G
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1018-1029. PubMed ID: 27650488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
    Gionchetti P; D'Arienzo A; Rizzello F; Manguso F; Maieron R; Lecis PE; Valpiani D; Iaquinto G; Annese V; Balzano A; Varoli G; Campieri M;
    J Clin Gastroenterol; 2005 Apr; 39(4):291-7. PubMed ID: 15758622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: systemic and topical steroids in inflammatory bowel disease.
    Schölmerich J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():66-74. PubMed ID: 15352897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E; Beau P
    Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.
    Simsek M; Lissenberg-Witte BI; van Riswijk MLM; Verschuren S; Hoentjen F; Oldenburg B; Ponsioen CY; van der Woude CJ; van der Meulen AE; Pierik M; Dijkstra G; de Boer NKH;
    Aliment Pharmacol Ther; 2019 May; 49(10):1293-1300. PubMed ID: 30908719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Manguso F; Bennato R; Lombardi G; Riccio E; Costantino G; Fries W
    PLoS One; 2016; 11(11):e0166455. PubMed ID: 27846307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the efficacy and safety of budesonide turbuhaler administered once daily with twice the dose of beclomethasone dipropionate using pressurised metered dose inhaler in patients with mild to moderate asthma.
    Ohaju-Obodo JO; Chukwu C; Okpapi J; Egbagbe E; Ige MO; Chukwuka C; Adedapo DA
    West Afr J Med; 2005; 24(3):190-5. PubMed ID: 16276692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budesonide in inflammatory bowel disease.
    Lamers CB; Wagtmans MJ; van der Sluys Veer A; van Hogezand RA; Griffioen G
    Neth J Med; 1996 Feb; 48(2):60-3. PubMed ID: 8819801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Budesonide-MMX in active ulcerative colitis.
    Gionchetti P; Praticò C; Rizzello F; Calafiore A; Capozzi N; Campieri M; Calabrese C
    Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):215-22. PubMed ID: 24502535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.
    Nunes T; Barreiro-de Acosta M; Nos P; Marin-Jiménez I; Bermejo F; Ceballos D; Iglesias E; Gomez-Senent S; Torres Y; Ponferrada A; Arevalo JA; Hernandez V; Calvet X; Ginard D; Monfort D; Chaparro M; Manceñido N; Domínguez-Antonaya M; Villalón C; Perez-Calle JL; Muñoz C; Nuñez H; Carpio D; Aramendiz R; Bujanda L; Estrada-Oncins S; Hermida C; Barrio J; Casis MB; Dueñas-Sadornil MC; Fernández L; Calvo-Cenizo MM; Botella B; de Francisco R; Ayala E; Sans M;
    J Crohns Colitis; 2010 Dec; 4(6):629-36. PubMed ID: 21122572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F; Wagner AC; Göke B
    Schweiz Med Wochenschr; 2000 Feb; 130(7):222-32. PubMed ID: 10719713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
    Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
    Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budesonide multi-matrix system formulation for treating ulcerative colitis.
    Prantera C; Scribano ML
    Expert Opin Pharmacother; 2014 Apr; 15(6):741-3. PubMed ID: 24484392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.